79 related articles for article (PubMed ID: 9703826)
1. [Stimulation of asialoglycoprotein receptor activity after transcatheter arterial embolotherapy in clinical study and continuous infusion of human hepatocyte growth factor in rat].
Hakawa SK; Kouda K; Tanaka Y
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1352-4. PubMed ID: 9703826
[TBL] [Abstract][Full Text] [Related]
2. Increased technetium-99m-GSA uptake per hepatocyte in rats with administration of dimethylnitrosamine or hepatocyte growth factor.
Kouda K; Ha-Kawa SK; Tanaka Y
J Nucl Med; 1998 Aug; 39(8):1463-7. PubMed ID: 9708531
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of asialoglycoprotein uptake by recombinant human hepatocyte growth factor in normal and damaged rat liver.
Kouda K; Ha-Kawa SK; Tanaka Y
Scand J Gastroenterol; 1997 Dec; 32(12):1267-71. PubMed ID: 9438327
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signalling pathways mediated by protein kinase C.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):271-8. PubMed ID: 7827802
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin.
Kudo M; Todo A; Ikekubo K; Yamamoto K; Vera DR; Stadalnik RC
Hepatology; 1993 May; 17(5):814-9. PubMed ID: 8491449
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
7. Technetium Tc 99m DTPA galactosyl human serum albumin to measure changes in hepatic functional reserve after transcatheter arterial embolization of the liver.
Hama Y; Kosuda S; Iwasaki Y; Kaji T; Kusano S
Can Assoc Radiol J; 2001 Dec; 52(6):399-403. PubMed ID: 11780551
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
Shiota G; Okano J; Kawasaki H; Kawamoto T; Nakamura T
Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
Kaneko A; Hayashi N; Tanaka Y; Ito T; Kasahara A; Kubo M; Mukuda T; Fusamoto H; Kamada T
Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
[TBL] [Abstract][Full Text] [Related]
10. Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepato-cellular carcinoma.
Yamazaki H; Oi H; Matsumoto K; Matsushita M; Ozeki S; Teshima T; Murayama S; Inoue T; Nakamura T; Inoue T
Cytokine; 1996 Feb; 8(2):178-82. PubMed ID: 8777277
[TBL] [Abstract][Full Text] [Related]
11. Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats.
Kaido T; Yoshikawa A; Seto S; Yamaoka S; Sato M; Ishii T; Imamura M
Hepatology; 1998 Sep; 28(3):756-60. PubMed ID: 9731569
[TBL] [Abstract][Full Text] [Related]
12. [Change in lobar uptake of 99mTc-galactosyl serum albumin after transarterial embolization therapy].
Kohda K; Ha-Kawa SK; Yamano R; Murata T; Harima K; Tanaka Y; Koreeda C; Inoue K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Dec; 54(14):1427-9. PubMed ID: 7596775
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m-GSA clearance in mice under long-term dietary restriction.
Kouda K; Kohno H; Nakamura H; Ha-Kawa SK; Sonoda Y; Iki M
Ann Nucl Med; 2009 Feb; 23(2):123-9. PubMed ID: 19225934
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats.
Hasuike S; Ido A; Uto H; Moriuchi A; Tahara Y; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
J Gastroenterol Hepatol; 2005 Nov; 20(11):1753-61. PubMed ID: 16246197
[TBL] [Abstract][Full Text] [Related]
15. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
16. Perioperative changes in hepatic function as assessed by asialoglycoprotein receptor indices by technetium 99m galactosyl human serum albumin.
Tanaka A; Shinohara H; Hatano E; Sato S; Kanazawa A; Yamaoka Y; Torizuka T; Konishi J; Tamaki N
Hepatogastroenterology; 1999; 46(25):369-75. PubMed ID: 10228824
[TBL] [Abstract][Full Text] [Related]
17. c-Met responsiveness of isolated hepatocytes evaluated in an in vitro de-differentiation model.
Boost KA; Kim HJ; Engl T; Oppermann E; Jonas D; Oertl A; Blaheta RA
Int J Mol Med; 2006 Mar; 17(3):475-82. PubMed ID: 16465395
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis.
Burr AW; Hillan KJ; McLaughlin KE; Ferrier R; Chapman C; Mathew J; Burt AD
Hepatology; 1996 Nov; 24(5):1282-7. PubMed ID: 8903411
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity.
Gao C; Jokerst R; Gondipalli P; Cai SR; Kennedy S; Flye MW; Ponder KP
Hepatology; 1999 Dec; 30(6):1405-16. PubMed ID: 10573519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
